We are live on ! Find out more
RhumbLine Advisers

RhumbLine Advisers Portfolio holdings

AUM $117B
1-Year Est. Return 29.66%
This Fund
S&P 500
This Quarter Est. Return
+12.75%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$104B
AUM Growth
+$8.72B
Cap. Flow
-$256M
Cap. Flow %
-0.25%
Top 10 Hldgs %
26.49%
Holding
4,372
New
62
Increased
2,195
Reduced
1,544
Closed
71

Top Buys

Rank Stock Value
1
AMZN icon
Amazon
AMZN
+$35.4M
2
P
Everpure Inc
P
+$21M
3
NVDA icon
NVIDIA
NVDA
+$20.7M
4
AMH icon
American Homes 4 Rent
AMH
+$19.3M
5
DAY
Dayforce
DAY
+$19M

Sector Composition

Rank Sector Weight
1 Technology 28.42%
2 Financials 13.09%
3 Healthcare 11.94%
4 Consumer Discretionary 10.95%
5 Industrials 9.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
RAIL icon
3601
FreightCar America
RAIL
$260M
$3.85K ﹤0.01%
1,001
KZIA
3602
Kazia Therapeutics
KZIA
$159M
$3.83K ﹤0.01%
243
+49
+25% +$734
CONN
3603
DELISTED
Conn's Inc.
CONN
$3.79K ﹤0.01%
1,131
DNK
3604
DELISTED
Phoenix Tree Holdings Limited American Depositary Shares, each representing ten (10) Class A ordinar
DNK
$3.74K ﹤0.01%
1,580
APLT
3605
DELISTED
Applied Therapeutics
APLT
$3.7K ﹤0.01%
544
TGS icon
3606
Transportadora de Gas del Sur
TGS
$4.33B
$3.7K ﹤0.01%
245
FRES
3607
DELISTED
Fresh2 Group Limited American Depositary Shares
FRES
$3.67K ﹤0.01%
668
UFI icon
3608
UNIFI
UFI
$134M
$3.65K ﹤0.01%
609
QNRX
3609
Quoin Pharmaceuticals
QNRX
$9.62M
$3.6K ﹤0.01%
109
+79
+263% +$7.79K
CALT
3610
DELISTED
Calliditas Therapeutics AB American Depositary Shares
CALT
$3.55K ﹤0.01%
164
TMIC
3611
DELISTED
TREND MICRO INC SPONS ADR-NEW
TMIC
$3.54K ﹤0.01%
70
EARN
3612
Ellington Residential Mortgage REIT
EARN
$165M
$3.54K ﹤0.01%
513
FIRY
3613
Firy Inc
FIRY
$163M
$3.54K ﹤0.01%
546
SYRS
3614
DELISTED
Syros Pharmaceuticals, Inc. Common Stock
SYRS
$3.52K ﹤0.01%
659
LWAY icon
3615
Lifeway Foods
LWAY
$481M
$3.44K ﹤0.01%
200
-1,200
-86% -$15.4K
SCNI
3616
Scinai Immunotherapeutics
SCNI
$1.27M
$3.44K ﹤0.01%
665
+134
+25% +$691
STLN
3617
Starling Oncology, Inc. Common Stock
STLN
$641M
$3.44K ﹤0.01%
2,175
LU icon
3618
Lufax Holding
LU
$1.3B
$3.4K ﹤0.01%
805
-11,569
-93% -$32.4K
CUK
3619
DELISTED
Carnival PLC
CUK
$3.39K ﹤0.01%
230
-74
-24% -$1.09K
LFVN icon
3620
LifeVantage
LFVN
$85.3M
$3.36K ﹤0.01%
556
OPRT icon
3621
Oportun Financial
OPRT
$372M
$3.3K ﹤0.01%
1,357
AHT
3622
Ashford Hospitality Trust
AHT
$21M
$3.24K ﹤0.01%
236
-226
-49% -$3.48K
PXLW icon
3623
Pixelworks
PXLW
$41.6M
$3.23K ﹤0.01%
104
RDNW
3624
RideNow Group
RDNW
$262M
$3.18K ﹤0.01%
493
CBIO
3625
Crescent Biopharma
CBIO
$626M
$3.13K ﹤0.01%
10

Similar funds

RhumbLine Advisers's Q1 2024 Portfolio in Review

As of Q1 2024, RhumbLine Advisers held 4,372 positions worth $104B, up 9.1% from $95.4B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

Trading was light in Q1 2024: portfolio turnover was 3%. RhumbLine Advisers opened 62 new positions and exited 71, leaving the 4,372-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.

  • RhumbLine Advisers's largest Q1 2024 buy was Dayforce: 278,394 shares worth $18.4M.
  • RhumbLine Advisers added most to Amazon in Q1 2024, an estimated $35.4M increase.
  • RhumbLine Advisers's biggest Q1 2024 reduction was Procter & Gamble, cutting an estimated $46.7M.
  • RhumbLine Advisers fully exited Splunk Inc in Q1 2024, selling an estimated $32.3M.
  • RhumbLine Advisers's ten largest holdings make up 26% of its $104B portfolio in Q1 2024.
  • RhumbLine Advisers opened 62 new positions and closed 71 in Q1 2024.
  • RhumbLine Advisers's portfolio value rose 9.1% quarter-over-quarter to $104B.

Based on RhumbLine Advisers's 13F filing for Q1 2024, filed 9 May 2024.